{"title": "Sexuell \u00fcbertragbare Infektionen: Epidemiologie und Management", "author": "PHC Primary; Hospital Care; Philip E Tarr; Isabella C Schoepf; Milena Hunziker; Jonathan Surber; Barbara Bertisch; Benjamin Hampel; Anne Meynard; Maja Brenner Cortazar; Regina Kulier; Rolf Egli; Tanja Grandinetti; Gisela Etter; Lena G Dietrich; David Haerry; Svend Capol; Karoline Aebi Popp; Simon M\u00fcller; Axel J Schmidt", "url": "https://phc.swisshealthweb.ch/de/article/doi/phc-d.2022.10556/", "hostname": "swisshealthweb.ch", "description": "In der Schweiz beobachten wir einen deutlichen Aufw\u00e4rtstrend bei den gemeldeten sexuell \u00fcbertragbaren Infektionen. Die Gr\u00fcnde daf\u00fcr sind vor allem vermehrte Testung, wie das nicht empfohlene Routine-Chlamydien-Screening bei sexuell aktiven Frauen, regelm\u00e4ssige Testkampagnen f\u00fcr M\u00e4nner, die Sex mit M\u00e4nnern haben und die stark gesunkenen Kosten f\u00fcr STI-Tests.", "sitename": "Philip E. Tarr,Isabella C. Schoepf,Milena Hunziker,Jonathan Surber,Barbara Bertisch,Benjamin Hampel,Anne Meynard,Maja Brenner Cortazar,Regina Kulier,Rolf Egli,Tanja Grandinetti,Gisela Etter,Lena G. Dietrich,David Haerry,Svend Capol,Karoline Aebi Popp,Simon M\u00fcller,Axel J. Schmidt", "date": "2022-10-05", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "1. Hermann M, Bosshardt L, Milic T, Nowak M. Sex in der Schweiz- eine Studie der Forschungsstelle sotomo im Auftrag der LOVE LIFE-Kampagne, Z\u00fcrich. Published online 2016.\n2. Gindi R, Ghanem K, Erbelding E. Increases in Oral and Anal Sexual Exposure Among Youth Attending Sexually Transmitted Diseases Clinics in Baltimore, Maryland. J Adolesc Heal. 2008;42(3):307\u20138\n3. Mercer CH, Tanton C, Prah P, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: Findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382:1781-1794.\n4. Nguyen N, Nguyen L, Thomas S, et al. Oral cancer and oropharyngeal cancer- The role of the primary care physicians. Otolaryngol - Head Neck Surg. 2016;88(11):802-806.\n5. Chow E, Cornelisse V, Williamson D, et al. Kissing may be an important and neglected risk factor for oropharyngeal gonorrhoea: A cross-sectional study in men who have sex with men. Sexually Transmitted Infections. 2019;95:516\u2013531.\n6. Randolph M, Pinkerton S, Bogart L, Cecil H, Abramson P. Sexual Pleasure and Condom Use. Arch Sex Behav. 2007;36(6):844-848.\n7. Higgins, J. A. and Wang, Y. The role of young adults\u2019 pleasure attitudes in shaping condom use. American Journal of Public Health. 2015;105:1329\u20131332.\n8. Schmidt AJ, Rasi M, Esson C, et al. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men. Swiss medical weekly. 2020;150:w20392.\n9. Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane HIV/AIDS Group, editor. Cochrane Database of Systematic Reviews [Internet]. 2002 Jan 21; Available from: http://doi.wiley.com/10.1002/14651858.CD003255 (Accessed 28.01.2021).\n10. Dietrich L, Notter J, Huber B, et al. HPV-Impfung : Update 2019 f\u00fcr die Impfberatung. Swiss Med Forum. 2019;19:220-226.\n11. Holmes K, Levine R, Weaver, M. Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization. 2004;82(6):454 \u2013 461.\n12. Warner L, Stone KM, Macaluso M, Buehler JW, Austin HD. Condom use and risk of gonorrhea and chlamydia: A systematic review of design and measurement factors assessed in epidemiologic studies. Sexually Transmitted Diseases. 2006;33:36\u201351.\n13. Crosby R, Charnigo RA, Weathers C, Caliendo AM, Shrier LA. Condom Effectiveness against Non-Viral Sexually Transmitted Infections: A Prospective Study Using Electronic Daily Diaries. Sex Transm Infect. 2012;88:484\u2013489.\n14. Wald A, Langenberg AGM, Link K, et al. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. J Am Med Assoc. 2001;285(24):3100-3106.\n15. Jungmann E. Genital herpes. Clin Evid (Online). 2007;(4):1-17.\n16. Goodyear-Smith F. What is the evidence for non-sexual transmission of gonorrhoea in children after the neonatal period? A systematic review. Journal of Forensic and Legal Medicine. 2007;14:489\u2013502.\n17. Goodyear-Smith F, Schabetsberger R. Gonococcus infection probably acquired from bathing in a natural thermal pool: a case report. Journal of Medical Case Reports. 2021;15:1\u20135.\n18. Scharf R. Im Gespr\u00e4ch mit \u2026 PD Dr. med. Philip Bruggmann. PraxisDepesche 03.2018.:8-10.\n19. Bundesgesundheitsministerium Deutschland. Sexuell \u00fcbertragbare Infektionen (STI) [Internet]. 2019 Available from https//www.bundesgesundheitsministerium.de/service/begriffe-von-a-z/s/sexuell-uebertragbare-infektionen-sti.html (Accessed 29.01.2021).\n20. Vernazza P, Hirschel B, Bernasconi E FM. HIV-infizierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nicht infekti\u00f6s. Schweizerische Arztezeitung. 2008;165\u20139.\n21. Itin P, Bosshard P, Trellu L, et al. Syphilis: Diagnostik und Behandlung. Swiss Med Forum \u2012 Schweizerisches Medizin-Forum. 2015;19:459\u201365.\n22. Burchell AN, Coutl\u00e9e F, Tellier PP, Hanley J, Franco EL, Genital Transmission of Human Papillomavirus in Recently Formed Heterosexual Couples. J Infect Dis. 2011;204(11):1723\u2013172.\n23. Benn P, Fisher M, Kulasegaram R. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure. Int J STD AIDS. 2011;22(12):695-708.\n24. https://kssg.guidelines.ch/guideline/1678/5629 (Accessed 01.05.2020).\n25. Rodger AJ, Cambiano V, Phillips AN, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019;393(10189):2428-2438.\n26. Schmidt AJ, Bourne A, Weatherburn P, et al. Illicit drug use among gay and bisexual men in 44 cities:\nFindings from the European MSM Internet Survey (EMIS). International Journal of Drug Policy. 2016;\n38:4\u201312.\n27. Giraudon I, Schmidt AJ, Mohammed H. Surveillance of sexualised drug use \u2013 the challenges and the opportunities. International Journal of Drug Policy. 2018;, 55:149\u2013154.\n28. Macgregor L, Kohli M, Looker K, et al. Chemsex and diagnoses of syphilis, gonorrhoea and chlamydia among men who have sex with men in the UK: A multivariable prediction model using causal inference methodology. Sexually Transmitted Infections. 2021;1\u20138.\n29. Doran J, Weatherburn P, Hickson F, et al. An update on the performance of STI services for gay and bisexual men across European cities: Results from the 2017 European MSM Internet Survey. Sexually Transmitted Infections. 2020;1\u20138.\n30. Marcus U, Mirandola M, Schink SB, Gios L, Schmidt AJ. Changes in the prevalence of self-reported sexually transmitted bacterial infections from 2010 and 2017 in two large European samples of men having sex with men-is it time to reevaluate STI-screening as a control strategy? PLoS ONE. 2021;16:1\u201324.\n31. Bundesamt f\u00fcr Gesundheit (BAG). HIV, Syphilis, Gonorrhoe und Chlamydiose in der Schweiz im Jahr 2019: eine epidemiologische \u00dcbersicht. BAG Bull. 2019;48(November):8-37.\n32. Bundesamt f\u00fcr Gesundheit BAG.Sexuell \u00fcbertragbare Infektionen (STI) in der Schweiz 1988 bis 2006: Aktueller Stand und Ausblick. BAG Bull. 2008;08:140-149.\n33. Schweizerische Herzstiftung. Aktiv gegen Herzkrankheiten und Hirnschlag. Coronavirus. 22.04.2020, Updat 30.01.2021 Avaiable from https//www.swissheart.ch/herzkrankheiten-hirnschlag/leben-mit-der-krankheit/coronavirus-covid-19-fragen-und-antworten.html (Accessed 10.02.2021).\n34. Bundesamt f\u00fcr Gesundheit BAG. HIV und Aids in der Schweiz im Jahr 2020. BAG-Bulletin. 2021;48:21.\n35. Bundesamt f\u00fcr Gesundheit BAG. HIV-Test und Beratung auf Initiative des Arztes, der \u00c4rztin. BAG Bulletin. 2015;21:237\u2013241.\n36. Eidgen\u00f6ssische Kommission f\u00fcr Sexuelle Gesundheit. Empfehlungen der Eidgen\u00f6ssischen Kommission f\u00fcr sexuelle Gesundheit (EKSG) zur HIV Pr\u00e4- Expositionsprophylaxe (PrEP) in der Schweiz. BAG Bulletin. 2016;77\u20139.\n37. Schoepf I, Haerry D, Tarr P. HIV Prophylaxe. Pharmakritik. 2021;42(6)PK1135\n38. Weber M, Nicca D, Schmidtd AJ, et al. HIV-Pr\u00e4-Expositionsprophylaxe in der Schweiz. Swiss Med Forum. 2021;21(37\u201338):632\u2013636.\n39. Traeger MW, Schroeder SE, Wright EJ, et al. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis. Clin Infect Dis. 2018;67(5):676-686.\n40. Traeger MW, Cornelisse VJ, Asselin J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. Jama. 2019;321(14):1380-1390.\n41. Gandhi M, Spinelli M, Mayer K. Addressing the sexually transmitted Infection and HIV Syndemic. JAMA. 2019;321(14):1356-1358.\n42. Grulich AE, Guy R, Amin J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629-e637.\n43. McCormack S. What happens when PrEP is scaled up? Results from EPIC-NSW. Lancet HIV. 2018;5(11):e607-e608.\n44. Tarr P, El Boffi Amari E, Haerry D, Fehr J, Calmy A. HIV-Pr\u00e4-Expositionsprophylaxe (PrEP). Swiss Med Forum \u2012 Schweizerisches Medizin-Forum. 2017;17:579-582.\n45. Owens DK, Davidson KW, Krist AH, et al. Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement. JAMA. 2019;321(22):2203-2213.\n46. Scott H, Volberding PA. HIV screening and preexposure prophylaxis guidelines: Following the evidence. JAMA -. 2019;321(22):2172-2174.\n47. Fauci A, Redfield R, Sigounas G, Weahkee M, Gionoir B. Applying public health principles to the HIV epidemic-how are we doing? N Engl J Med. 2019;373(23):2281-2287.\n48. Smith DK, Sullivan PS, Cadwell B, et al. Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012\u20132016. Clin Infect Dis. Published online 2020:1-8.\n49. Schmidt AJ and Altpeter E. The Denominator problem: Estimating the size of local populations of men-who-have-sex-with-men and rates of HIV and other STIs in Switzerland. Sexually Transmitted Infections. 2019;95:285\u2013291.\n50. Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis. J. Eur Acad Dermatol Venereol. 2014;28(12):1581\u201393.\n51. Lunny C, Taylor D, Hoang L, et al. Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: A systemic review and meta-analysis. PLoS One. 2015;10(7):1-23.\n52. Berry L, Stanley B. Comparison of self-collected meatal swabs with urine specimens for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men. J Med Microbiol. 2017;66(2):134-136.\n53. Feltner C, Grodensky C, Ebel C, et al. Serologic screening for genital herpes: An updated evidence report and systematic review for the US preventive services task force. JAMA - J Am Med Assoc. 2016;316(23):2531-2543.\n54. Hook EW. A recommendation against serologic screening for genital herpes infection-what now? JAMA - J Am Med Assoc. 2016;316(23):2493-2494.\n55. American Academy of Family Physicians Choosing Wisely Recommendation: Don\u2019t screen for genital herpes simplex virus infection (HSV) in asymptomatic adults, including pregnant women. [Internet]. 2018 Aug Available from https//www.aafp.org/dam/AAFP/documents/about_us/initiatives/choosing-wisely-questions.pdf (Accessed 10.02.2021).\n56. Marcus JL, Paltiel AD, Walensky RP. Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out. Clin Infect Dis. Published online 2020:1-2.\n57. Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in Acute and Chornic Nongonococcal Urethritis. Clin Infect Dis. 2001;32:995-1003.\n58. Wetmore CM, Manhart LE, Lowens MS, et al. Ureaplasma urealyticum is associated with nongonococcal urethritis among men with fewer lifetime sexual partners: A case-control study. J Infect Dis. 2011;204(8):1274-1282.\n59. Gwee A, Curtis N. Ureaplasma - Are you sitting comfortably? J Infect. 2014;68(SUPPL1):S19-S23.\n60. Workowski K, Bolan G. STD Treatment Guidelines CDC. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. Avaiable from https//www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm (Accessed 12.02.2021). 2015;64:140.\n61. Bundesamt f\u00fcr Gesundheit BAG. Dringliche \u00c4nderungen per 1. Dezember 2020 der Analysenliste (Anhang 3 KLV). BAG Bulletin. 2020;44:9.\n62. Sultan B, White J, Fish R, et al. The \u201c3 in 1\u201d Study: Pooling Self-Taken Pharyngeal, Urethral, and Rectal Samples into a Single Sample for Analysis for Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in Men Who Have Sex with Men. Journal of Clinical Microbiology. 2016;54:650\u2013656.\n63. British Association for Sexual Health and HIV (BASHH). British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium 2018 [Internet]. Available from https//www.bashhguidelines.org/current-guidelines/urethritis-and-cervicitis/mycoplasma-genitalium-2018/ (Accessed 09022021). Published online 2019.\n64. Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV (Bashh) national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019;30(10):938-950.\n65. Notter J, Frey Tirri B, Bally F, et al. Sexuell \u00fcbertragene Infektionen mit Chlamydia trachomatis. Swiss Med Forum. 2017;17(34).\n66. Tarr P. Sexuell \u00fcbertragene Infektionen mit Chlamydia trachomatis : Empfehlungen der Eidgen\u00f6ssischen Kommission f\u00fcr Sexuelle Gesundheit ( EKSG ) und der Schweizerischen Gesellschaft f\u00fcr Infektiologie ( SSI ). BAG Bull. 2017;(August):8-14.\n67. British Association for Sexual Health and HIV (BASHH). 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae [Internet]. Available from https//bashh.org/guidelines (Accessed 10.02.2021). Published online 2020.\n68. Fifer H, Saunders J, Soni S, Sadiq ST, FitzGerald M. 2018 UK national guideline for the management of infection with Neisseria gonorrhoeae (British Association for Sexual Health and HIV). Int J STD AIDS. 2020;31(1):4-15.\n69. Anic GM, Lee JH, Stockwell H, et al. Incidence and human papillomavirus (HPV) type distribution of genital warts in a multinational cohort of men: The HPV in men study. J Infect Dis. 2011;204(12):1886-1892.\n70. Trellu T, Oertle, D Itin, P Furrer, H Scheidegger, C Stoeckle, M Schmid, P Bernasconi, E Cavassini, M Boffi El Amari, E Kahlert C, Vernazza, P Fehr, J Calmy, A Low, N Martinetti Lucchini, G Tarr P. Gonorrhoe: neue Empfehlungen zu Diagnostik und Behandlung. Swiss Med Forum. 2014;14(20).\n71. Bundesamt f\u00fcr Gesundheit BAG. HPV-Impfung: erg\u00e4nzende Impfempfehlung f\u00fcr Jungen und M\u00e4nner im Alter von 11 bis 26 Jahren. BAG Bull. 2015;10:141\u20139.\n72. Surber J, Hunziker M, Navarria I, et al. Genitalherpes \u2013 Update 2020 f\u00fcr die Praxis. Prim Hosp Care Allg Inn Medizin. 2020;20(3):100-104.\n73. Bundesamt f\u00fcr Gesundheit BAG. Bundesamt f\u00fcr Gesundheit BAG. Chlamydiose [Internet]. 2019 Dec. Available from: https://www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/chlamydiose.html (Accessed 29.01.2021).\n74. Bundesamt f\u00fcr Gesundheit BAG. Bundesamt f\u00fcr Gesundheit BAG. Gonorrhoe (Tripper) [Internet]. 2019 Dec. Available from: https://www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/gonorrhoe.html (Accessed 29.01.2021).\n75. Huber F, Beise U. Sexuell \u00fcbertragbare Krankheiten. medix STD. Published online 2019:1-8.\n76. Bundesamt f\u00fcr Gesundheit BAG. Syphilis in der Schweiz im Jahr 2016. BAG-Bulletin. 2017;43:20-24.\n77. Schmutz C, Burki D, Frei R, M\u00e4usezahl-Feuz M, M\u00e4usezahl D. Testing for Chlamydia trachomatis: Time trends in positivity rates in the canton of Basel-Stadt, Switzerland. Epidemiol Infect. 2013;141(9):1953-1964.\n78. Grossmann A. Sexuell \u00fcbertragbare Krankheiten in der Schweiz \u2013 Stand 2017. Dermatologie Prax. 2017;27(3):1-3.\n79. Price MJ, Ades A, Soldan K, Welton NJ, Macleod J, Simms I, DeAngelis D, Turner KM HP. The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. Health Technol Assess (Rockv). 2016;20(22):1-25'.\n80. Davies B, Turner KME, Fr\u00f8lund M, et al. Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. Lancet Infect Dis. 2016;16(9):1057-1064.\n81. Bundesamt f\u00fcr Gesundheit BAG. Chlamydiose in der Schweiz im Jahr 2016. BAG Bulletin.\n82. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I HP. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;(340(apr08 1):c1642\u2013c1642.).\n83. Low N, Unemo M, Skov Jensen J, Breuer J, Stephenson JM. Molecular Diagnostics for Gonorrhoea: Implications for Antimicrobial Resistance and the Threat of Untreatable Gonorrhoea. PLoS Med. 2014;11(2).\n84. Dombrowski JC, Wierzbicki MR, Newman LM, et al. DoDoxycycline Versus Azithromycin for the Treatment of Rectal Chlamydia in Men who have Sex with Men: A Randomized Controlled Trial. Biomedgerontology. 2020;19:ciab153.\n85. Rank RG, Yeruva L. Hidden in plain sight: Chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infect Immun. 2014;82(4):1362-1371.\n86. Gratrix J, Singh AE, Bergman J, et al. Evidence for increased chlamydia case finding after the introduction of rectal screening among women attending 2 Canadian sexually transmitted infection clinics. Clin Infect Dis. 2015;60(3):398-404.\n87. Heijne JCM, Van Liere GAFS, Hoebe CJPA, Bogaards JA, Van Benthem BHB, Dukers-Muijrers NHTM. What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies. Sex Transm Infect. 2017;93(4):270-275.\n88. Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol. 2010;5(9):1427-1442.\n89. Stamm L V. Syphilis: Antibiotic treatment and resistance. Epidemiol Infect. 2015;143(8):1567-1574.\n90. Kimberlin D, Dwight R. Genital herpes. N Engl J Med. 2004;(11):2073-2088.\n91. da Costa-Louren\u00e7o APR, Barros dos Santos KT, Meurer Moreira B, Fracalanzza SEL, Bonelli RR. Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat. Brazilian J Microbiol. 2017;48(4):617-628.\n92. Tarr PE. Richtline: Gonorrhoe/Tripper (N . gonorrhoea) [Internet]. SSIGuidelines 2020 Jan Available from https//ssi.guidelines.ch/guideline/2272 (Accessed 09.02.2021). (D):2-4.\n93. International Union against Sexually Transmitted Infections IUSTI. 2020 European guideline for the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. Published online 2020.\n94. Mueller SM, Menzi S, Kind AB, et al. Sexually transmitted coinfections in patients with anogenital warts \u2013 a retrospective analysis of 196 patients. JDDG - Journal of the German Society of Dermatology. 2020;18:325\u2013332.\n95. Drolet M, B\u00e9nard \u00c9, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: A systematic review and meta-analysis. The Lancet Infectious Diseases. 2015;15:565\u2013580.\n96. Blomberg M, Dehlendorff C, Munk C, Kjaer SK. Strongly decreased risk of genital warts after\nvaccination against human papillomavirus: Nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clinical Infectious Diseases. 2013;57:929\u2013934\n97. Cho CY, Lo YC, Hung MC, et al. Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan. PLoS ONE. 2017;12:1\u201315.\n98. International Union against Sexually Transmitted Infections IUSTI. 2019 IUSTI-Europe guideline for the management of anogenital warts. Journal of the European Academy of Dermatology and Venereology. 2020;34:1644\u20131653.\n99. Jung J, Jung C, Lee W, et al. Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis. British Journal of Dermatology. 2020;183:24\u201336.\n100. Fr\u00f6hlich Knaute D, Graf N, Lautenschlager S, Weber R, Bosshard P. Serological response to treatment of syphilis according to disease stage and HIV status. Clin Infect Dis. 2012;55:1615\u20131622.\n101. Bundesamt f\u00fcr Gesundheit BAG. Syphilis: aktualisierte Empfehlungen zu Diagnostik und Behandlung. BAG Bull. 2015;21:242-247.\n102. Clement M, Okeke N, Hicks C. Treatment of syphilis: a systematic review. JAMA. 2014;312:1905\u20131917.\n103. Markowitz M. Benzathine Penicillin After Thirty Years. Clinical Therapeutics. 1980;3:49\u201361.\n104. Peter G, Dudley MN. Clinical Pharmacology of Benzathine Penicillin G. Pediatric Infectious Disease. 1985;4:586\u2013591.\n105. Gonz\u00e1lez-L\u00f3pez JJ, Fern\u00e1ndez Guerrero ML, Luj\u00e1n R, De G\u00f3rgolas M, Requena L. Factors determining serologic response to treatment in patients with syphilis. Clin Infect Dis. 2009;49(10):1505-1511.\n106. Golden MR, Marra CM, King HK. Update on Syphilis Resurgence of an Old Problem. JAMA - J Am Med Assoc. 2003;290(11):1510-1514.\n107. Ghanem KG, Ram S, Rice PA. The Modern Epidemic of Syphilis. N Engl J Med. 2020;382:845-854.\n108. Hansen BT, Kj\u00e6r SK, Arnheim-Dahlstr\u00f6m L, et al. Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: Evidence from a large survey of Nordic women. Vaccine. 2014;32(39):4945-4953.\n109. Bundesamt f\u00fcr Gesundheit BAG. Die HPV-Impfung in der Schweiz: Resultate einer nationalen Befragung im Jahr 2014. BAG Bull. 2015;23:445\u201352.\n110. Svarrer RO, Rasmussen AL, Lauszus FF, Hammer A. No effect of human papillomavirus vaccination on sexual debut of school children. Dan Med J. 2019;66(4):1-5.\n111. Marlow LAV, Forster AS, Wardle J, Waller J. Mothers\u2019 and Adolescents\u2019 Beliefs about Risk Compensation following HPV Vaccination. J Adolesc Heal. 2009;44(5):446-451.\n112. Grandahl M, Tyd\u00e9n T, Westerling R, et al. To Consent or Decline HPV Vaccination: A Pilot Study at the Start of the National School-Based Vaccination Program in Sweden. J Sch Health. 2017;87(1):62-70.\n113. Vivancos R, Abubakar I, Phillips-Howard P, Hunter PR. School-based sex education is associated with reduced risky sexual behaviour and sexually transmitted infections in young adults. Public Health. 2013;127(1):53-57.\n114. Kessler C, Blake C, Gerold J, Zahorka M. Expertenbericht:Sexualaufkl\u00e4rung in der Schweiz mit Bezug zu internationalen Leitpapieren und ausgew\u00e4hlten Vergleichsl\u00e4ndern. Expertengruppe Sexualaufkl\u00e4rung, Bern, Public Health Services, Bern, Schweizerisches Tropen- und Public Health- Institut, Basel. Published online 2017:51-64.\n115. Sander PM, Raymond EG, Weaver MA. Emergency contraceptive use as a marker of future risky sex, pregnancy, and sexually transmitted infection. Am J Obstet Gynecol. 2009;201(2):146.e1-146.e6.\n116. Meyer JL, Gold MA, Haggerty CL. Advance Provision of Emergency Contraception among Adolescent and Young Adult Women: A Systematic Review of Literature. J Pediatr Adolesc Gynecol. 2011;24(1):2-9.\n117. Habel M, Leichliter J. Emergency Contraception and Risk for Sexually Transmitted Infections Among U.S. Women. J Womens Heal. 2012;21(9):910-916.\n118. Bodmer N, Cirigliano L, Demeter D, et al. Jugendsexualit\u00e4t im Wandel der Zeit: Ver\u00e4nderungen, Einfl\u00fcsse, Perspektiven. Eidgen\u00f6ssische Kommission f\u00fcr Kinder und Jugendfragen EKKJ. Avaiable from https//ekkj.admin.ch/themen/sexualitaet (Accessed 12.02.2021). Published online 2009:29-48.\n119. Bundesamt f\u00fcr Gesundheit BAG. \u00abAuf gehts\u00bb \u2013 das Kondom als Botschaftstr\u00e4ger der neuen Kampagne LOVE LIFE [Internet]. 2019 Nov Available from https//www.bag.admin.ch/bag/de/home/das-bag/aktuell/news/news-04-11-2019.html (Accessed 10.02.20219).\n120. Carrillo JE, Green AR, Betancourt JR. Cross-Cultural Primary Care : A Patient-Based Approach. Annals of Internal Medicine. 1999;130:829\u2013834.\n121. Seibert PS, Stridh-Igo P, Zimmerman CG. A checklist to facilitate cultural awareness and sensitivity. Journal of Medical Ethics. 2002;28:143\u2013146.\n122. Misra-Hebert A. Physician cultural competence: cross-cultural communication improves care. Cleveland Clinic Journal of Medicine. 2003;70:296\u20138.\n123. Gawande A. Naked. New England Journal of Medicine. 2005;645\u2013648.\n124. Epner DE, Baile WF. Patient-centered care: The key to cultural competence. Annals of Oncology. 2012;23:33\u201342.\n125. Bundesamt f\u00fcr Gesundheit BAG. Der HIV-Test als wichtiges Element der HIV / STI-Pr\u00e4vention. BAG Bull. 2011;27:555\u201362.\n126. Bundesamt f\u00fcr Gesundheit BAG. Zielsetzungen und Richtlinie. BAG Bull. 2015;21:377-377\u20139.\n127. Vernazza P, Rasi M, Ritzler M, et al. The Swiss STAR trial \u2013 an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women. Swiss medical weekly. 2020;150:w2039", "language": null, "image": null, "pagetype": "article", "links": ["https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "#collapseSearch", "/de/article/doi/phc-d.2022.10556/", "/fr/article/doi/phc-f.2022.10556/", "https://www.swisshealthweb.ch/de/newsfeed/", "https://phc.swisshealthweb.ch/de/", "/de/", "/de/aktuelle-ausgabe/", "/de/archiv/", "/de/publizieren/", "/de/ueber-phc/", "https://www.swisshealthweb.ch/de/zeitschriften/", "https://shop.emh.ch/", "https://www.swisshealthweb.ch/de/encyclomed/", "https://events.emh.ch", "https://phc.swisshealthweb.ch/de/article/?tx_cs2services_teaser%5Baction%5D=serviceLinkHandler&tx_cs2services_teaser%5Bcontroller%5D=Services&tx_cs2services_teaser%5Bservice%5D=9&type=96529&cHash=957c22557b087f72957914479c8387b5", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "/de/article/doi/phc-d.2022.10556/", "/fr/article/doi/phc-f.2022.10556/", "https://events.emh.ch/", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", "https://shop.emh.ch/", null, "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2022/phc-d.2022.10556/phc-d-2022-10556.pdf", "#otherInfos", "/de/archiv/ausgabe/issue-doi/phc.2022.10/", "https://doi.org/10.4414/phc-d.2022.10556", "javascript:void(0)", "https://phc.swisshealthweb.ch/fileadmin/assets/PHC/2022/phc-d.2022.10556/phc-d-2022-10556.pdf", "https://emh.ch/en/emh/rights-and-licences/", "#top", null, null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "https://www.swisshealthweb.ch/de/informationen-und-services/qualitaetssicherung/", "https://www.swisshealthweb.ch/de/informationen-und-services/publizistische-leitlinien/", "https://www.swisshealthweb.ch/de/informationen-und-services/copyright/", "https://www.swisshealthweb.ch/de/informationen-und-services/newsletter/", "https://www.swisshealthweb.ch/de/verlag/ueber-emh/", "https://www.swisshealthweb.ch/de/verlag/inserieren/", "https://www.swisshealthweb.ch/de/verlag/jobs/", "https://www.swisshealthweb.ch/de/partner/", "https://www.swisshealthweb.ch/de/verlag/hilfe-und-kontakt/", "https://www.swisshealthweb.ch/de/agb/", "https://www.swisshealthweb.ch/de/verlag/impressum/", "https://www.swisshealthweb.ch/de/verlag/datenschutz/", "https://www.swisshealthweb.ch/de/verlag/disclaimer/", "javascript:void()"]}